Gut microbiota and metabolic health: The potential beneficial effects of a medium chain triglyceride diet in obese individuals

Nutrients

Volumn 8, Issue 5, 2016, Pages

  Rial, Sabri Ahmed ^a   Karelis, Antony D ^a   Bergeron, Karl F ^a   Mounier, Catherine ^a  

^a UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

Bacteroidetes; Endotoxemia; Firmicutes; Gut microbiota; Lipopolysaccharide; Medium chain fatty acids; Medium chain triglycerides; Metabolic syndrome; Metabolically healthy obese; Metabolically unhealthy obese; Non alcoholic fatty liver disease; Obesity

Indexed keywords

MEDIUM CHAIN TRIACYLGLYCEROL; TRIACYLGLYCEROL;

BODY WEIGHT MANAGEMENT; CARDIOVASCULAR DISEASE; COMORBIDITY; DIET THERAPY; ENDOTOXEMIA; ENERGY EXPENDITURE; HUMAN; INSULIN RESISTANCE; INTESTINE FLORA; INTESTINE MUCOSA PERMEABILITY; LIPOLYSIS; MEDIUM CHAIN TRIGLYCERIDE DIET; METABOLIC BALANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; REVIEW; WEIGHT REDUCTION; CHEMISTRY; DIET; FOOD ANALYSIS;

DIET; FOOD ANALYSIS; HUMANS; OBESITY; TRIGLYCERIDES;

EID: 84968543842     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8050281     Document Type: Review

References (159)

1. Smith, K.B.; Smith, M.S. Obesity statistics. Prim. Care 2016, 43, 121-135. [CrossRef] [PubMed]
2. Ng, M.; Fleming, T.; Robinson, M.; Thomson, B.; Graetz, N.; Margono, C.; Mullany, E.C.; Biryukov, S.; Abbafati, C.; Abera, S.F. et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: A systematic analysis for the global burden of disease study 2013. Lancet 2014, 384, 766-781 [CrossRef]
3. Haslam, D.W.; James, W.P. Obesity. Lancet 2005, 366, 1197-1209 [CrossRef]
4. Graffy, P.M.; Pickhardt, P.J. Quantification of hepatic and visceral fat by ct and mr imaging: Relevance to the obesity epidemic, metabolic syndrome and nafld. Br. J. Radiol. 2016, 89, 20151024. [CrossRef] [PubMed]
5. Grundy, S.M. Metabolic syndrome update. Trends Cardiovasc. Med. 2016, 26, 364-373. [CrossRef] [PubMed]
6. Hryhorczuk, C.; Sharma, S.; Fulton, S.E. Metabolic disturbances connecting obesity and depression. Front. Neurosci. 2013, 7, 177. [CrossRef] [PubMed]
7. Reuter, C.P.; Silva, P.T.; Renner, J.D.; Mello, E.D.; Valim, A.R.; Pasa, L.; Silva, R.D.; Burgos, M.S. Dyslipidemia is associated with unfit and overweight-obese children and adolescents. Arq. Brasil. Cardiol. 2016. [CrossRef] [PubMed]
8. Elmaogullari, S.; Tepe, D.; Ucakturk, S.A.; Karaca Kara, F.; Demirel, F. Prevalence of dyslipidemia and associated factors in obese children and adolescents. J. Clin. Res. Pediatr. Endocrinol. 2015, 7, 228-234. [CrossRef] [PubMed]
9. Cho, Y.; Shore, S.A. Obesity, asthma, and the microbiome. Physiology 2016, 31, 108-116. [CrossRef] [PubMed]
10. Payab, M.; Amoli, M.M.; Qorbani, M.; Hasani-Ranjbar, S. Adiponectin gene variants and abdominal obesity in an iranian population. Eat. Weight Disord. 2016. [CrossRef] [PubMed]
11. Waleh, M.Q. Impacts of physical activity on the obese. Prim. Care 2016, 43, 97-107. [CrossRef] [PubMed]
12. Scott, E.M. Circadian clocks, obesity and cardiometabolic function. Diabetes Obes. Metab. 2015, 17, 84-89. [CrossRef] [PubMed]
13. Klingenberg, L.; Sjodin, A.; Holmback, U.; Astrup, A.; Chaput, J.P. Short sleep duration and its association with energy metabolism. Obes. Rev. Off. J. Int. Assoc. Stud. Obes. 2012, 13, 565-577. [CrossRef] [PubMed]
14. Choudhury, S.M.; Tan, T.M.; Bloom, S.R. Gastrointestinal hormones and their role in obesity. Curr. Opin. Endocrinol. Diabetes Obes. 2016, 23, 18-22. [CrossRef] [PubMed]
15. Lee, D.H.; Porta, M.; Jacobs, D.R., Jr.; Vandenberg, L.N. Chlorinated persistent organic pollutants, obesity, and type 2 diabetes. Endocr. Rev. 2014, 35, 557-601. [CrossRef] [PubMed]
16. Nova, E.; Perez de Heredia, F.; Gomez-Martinez, S.; Marcos, A. The role of probiotics on the microbiota: Effect on obesity. Nutr. Clin. Pract. 2016. [CrossRef] [PubMed]
17. Patterson, E.; Ryan, P.M.; Cryan, J.F.; Dinan, T.G.; Ross, R.P.; Fitzgerald, G.F.; Stanton, C. Gut microbiota, obesity and diabetes. Postgrad. Med. J. 2016. [CrossRef] [PubMed]
18. Drewnowski, A.; Almiron-Roig, E. Frontiers in neuroscience human perceptions and preferences for fat-rich foods. In Fat Detection: Taste, Texture, and Post Ingestive Effects; Montmayeur, J.P., Le Coutre, J., Eds.; CRC Press/Taylor & Francis Group, LLC.: Boca Raton, FL, USA, 2010.
19. Strable, M.S.; Ntambi, J.M. Genetic control of de novo lipogenesis: Role in diet-induced obesity. Crit. Rev. Biochem. Mol. Biol. 2010, 45, 199-214. [CrossRef] [PubMed]
20. Ameer, F.; Scandiuzzi, L.; Hasnain, S.; Kalbacher, H.; Zaidi, N. De novo lipogenesis in health and disease. Metabol. Clin. Exp. 2014, 63, 895-902. [CrossRef] [PubMed]
21. Povero, D.; Feldstein, A.E. Novel molecular mechanisms in the development of non-alcoholic steatohepatitis. Diabetes Metabol. J. 2016, 40, 1-11. [CrossRef] [PubMed]
22. Kaila, B.; Raman, M. Obesity: A review of pathogenesis and management strategies. Can. J. Gastroenterol. 2008, 22, 61-68. [CrossRef] [PubMed]
23. Rankinen, T.; Zuberi, A.; Chagnon, Y.C.; Weisnagel, S.J.; Argyropoulos, G.; Walts, B.; Perusse, L.; Bouchard, C. The human obesity gene map: The 2005 update. Obesity 2006, 14, 529-644. [CrossRef] [PubMed]
24. Waterland, R.A.; Travisano, M.; Tahiliani, K.G.; Rached, M.T.; Mirza, S. Methyl donor supplementation prevents transgenerational amplification of obesity. Int. J. Obes. 2008, 32, 1373-1379. [CrossRef] [PubMed]
25. McAllister, E.J.; Dhurandhar, N.V.; Keith, S.W.; Aronne, L.J.; Barger, J.; Baskin, M.; Benca, R.M.; Biggio, J.; Boggiano, M.M.; Eisenmann, J.C. et al. Ten putative contributors to the obesity epidemic. Crit. Rev. Food Sci. Nutr. 2009, 49, 868-913. [CrossRef] [PubMed]
26. Kanayama, T.; Kobayashi, N.; Mamiya, S.; Nakanishi, T.; Nishikawa, J. Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor gamma/retinoid X receptor pathway. Mol. Pharmacol. 2005, 67, 766-774. [CrossRef] [PubMed]
27. Trayhurn, P.; Beattie, J.H. Physiological role of adipose tissue: White adipose tissue as an endocrine and secretory organ. Proc. Nutr. Soc. 2001, 60, 329-339. [CrossRef] [PubMed]
28. Maachi, M.; Pieroni, L.; Bruckert, E.; Jardel, C.; Fellahi, S.; Hainque, B.; Capeau, J.; Bastard, J.P. Systemic low-grade inflammation is related to both circulating and adipose tissue tnfalpha, leptin and il-6 levels in obese women. Int. J. Obes. Relat. Metab. Disord. 2004, 28, 993-997. [CrossRef] [PubMed]
29. Grover, S.A.; Kaouache, M.; Rempel, P.; Joseph, L.; Dawes, M.; Lau, D.C.; Lowensteyn, I. Years of life lost and healthy life-years lost from diabetes and cardiovascular disease in overweight and obese people: A modelling study. Lancet Diabetes Endocrinol. 2015, 3, 114-122. [CrossRef]
30. Roberts, C.K.; Hevener, A.L.; Barnard, R.J. Metabolic syndrome and insulin resistance: Underlying causes and modification by exercise training. Compr. Physiol. 2013, 3, 1-58. [PubMed]
31. Kyrou, I.; Randeva, H.S.; Weickert, M.O. Clinical problems caused by obesity. In Endotext; De Groot, L.J., Beck-Peccoz, P., Chrousos, G., Dungan, K., Grossman, A., Hershman, J.M., Koch, C., McLachlan, R., New, M., Rebar, R., et al., Eds.; MDText.com, Inc.: South Dartmouth, MA, USA, 2000.
32. Poirier, P.; Giles, T.D.; Bray, G.A.; Hong, Y.; Stern, J.S.; Pi-Sunyer, F.X.; Eckel, R.H. Obesity and cardiovascular disease: Pathophysiology, evaluation, and effect of weight loss: An update of the 1997 american heart association scientific statement on obesity and heart disease from the obesity committee of the council on nutrition, physical activity, and metabolism. Circulation 2006, 113, 898-918. [PubMed]
33. Fabbrini, E.; Sullivan, S.; Klein, S. Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications. Hepatology 2010, 51, 679-689. [CrossRef] [PubMed]
34. Samocha-Bonet, D.; Dixit, V.D.; Kahn, C.R.; Leibel, R.L.; Lin, X.; Nieuwdorp, M.; Pietilainen, K.H.; Rabasa-Lhoret, R.; Roden, M.; Scherer, P.E. et al. Metabolically healthy and unhealthy obese—The 2013 stock conference report. Obes. Rev. 2014, 15, 697-708. [CrossRef] [PubMed]
35. Karelis, A.D. Metabolically healthy but obese individuals. Lancet 2008, 372, 1281-1283. [CrossRef]
36. Primeau, V.; Coderre, L.; Karelis, A.D.; Brochu, M.; Lavoie, M.E.; Messier, V.; Sladek, R.; Rabasa-Lhoret, R. Characterizing the profile of obese patients who are metabolically healthy. Int. J. Obes. 2011, 35, 971-981. [CrossRef] [PubMed]
37. Velho, S.; Paccaud, F.; Waeber, G.; Vollenweider, P.; Marques-Vidal, P. Metabolically healthy obesity: Different prevalences using different criteria. Eur. J. Clin. Nutr. 2010, 64, 1043-1051. [CrossRef] [PubMed]
38. Wildman, R.P.; Muntner, P.; Reynolds, K.; McGinn, A.P.; Rajpathak, S.; Wylie-Rosett, J.; Sowers, M.R. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: Prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch. Intern. Med. 2008, 168, 1617-1624. [CrossRef] [PubMed]
39. Plourde, G.; Karelis, A.D. Current issues in the identification and treatment of metabolically healthy but obese individuals. Nutr. Metab. Cardiovasc. Dis. 2014, 24, 455-459. [CrossRef] [PubMed]
40. Eckel, N.; Meidtner, K.; Kalle-Uhlmann, T.; Stefan, N.; Schulze, M.B. Metabolically healthy obesity and cardiovascular events: A systematic review and meta-analysis. Eur. J. Prev. Cardiol. 2015. [CrossRef] [PubMed]
41. Loos, R.J. Integrating publicly available genome-wide association data to study the genetic basis of metabolically healthy obese and metabolically obese but normal-weight individuals. Diabetes 2014, 63, 4004-4007. [CrossRef] [PubMed]
42. Berezina, A.; Belyaeva, O.; Berkovich, O.; Baranova, E.; Karonova, T.; Bazhenova, E.; Brovin, D.; Grineva, E.; Shlyakhto, E. Prevalence, risk factors, and genetic traits in metabolically healthy and unhealthy obese individuals. Biomed. Res. Int. 2015, 2015, 548734. [CrossRef] [PubMed]
43. Kandasamy, A.D.; Sung, M.M.; Boisvenue, J.J.; Barr, A.J.; Dyck, J.R. Adiponectin gene therapy ameliorates high-fat, high-sucrose diet-induced metabolic perturbations in mice. Nutr. Diabetes 2012, 2, e45. [CrossRef] [PubMed]
44. Hur, K.Y.; Lee, M.S. Gut microbiota and metabolic disorders. Diabetes Metab. J. 2015, 39, 198-203. [CrossRef] [PubMed]
45. Guinane, C.M.; Cotter, P.D. Role of the gut microbiota in health and chronic gastrointestinal disease: Understanding a hidden metabolic organ. Ther. Adv. Gastroenterol. 2013, 6, 295-308. [CrossRef] [PubMed]
46. Chow, J.; Lee, S.M.; Shen, Y.; Khosravi, A.; Mazmanian, S.K. Host-bacterial symbiosis in health and disease. Adv. Immunol. 2010, 107, 243-274. [PubMed]
47. Kelly, C.J.; Zheng, L.; Campbell, E.L.; Saeedi, B.; Scholz, C.C.; Bayless, A.J.; Wilson, K.E.; Glover, L.E.; Kominsky, D.J.; Magnuson, A. et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial hif augments tissue barrier function. Cell Host Microb. 2015, 17, 662-671. [CrossRef] [PubMed]
48. Den Besten, G.; Lange, K.; Havinga, R.; van Dijk, T.H.; Gerding, A.; van Eunen, K.; Muller, M.; Groen, A.K.; Hooiveld, G.J.; Bakker, B.M. et al. Gut-derived short-chain fatty acids are vividly assimilated into host carbohydrates and lipids. Am. J. Physiol. Gastrointest. Liver Physiol. 2013, 305, G900-G910. [CrossRef] [PubMed]
49. Den Besten, G.; van Eunen, K.; Groen, A.K.; Venema, K.; Reijngoud, D.J.; Bakker, B.M. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J. Lipid Res. 2013, 54, 2325-2340. [CrossRef] [PubMed]
50. Singh, V.; Chassaing, B.; Zhang, L.; San Yeoh, B.; Xiao, X.; Kumar, M.; Baker, M.T.; Cai, J.; Walker, R.; Borkowski, K. et al. Microbiota-dependent hepatic lipogenesis mediated by stearoyl coa desaturase 1 (scd1) promotes metabolic syndrome in tlr5-deficient mice. Cell Metab. 2015, 22, 983-996. [CrossRef] [PubMed]
51. LeBlanc, J.G.; Milani, C.; de Giori, G.S.; Sesma, F.; van Sinderen, D.; Ventura, M. Bacteria as vitamin suppliers to their host: A gut microbiota perspective. Curr. Opin. Biotechnol. 2013, 24, 160-168. [CrossRef] [PubMed]
52. Janssen, A.W.; Kersten, S. The role of the gut microbiota in metabolic health. Fed. Am. Soc. Exp. Biol. J. 2015, 29, 3111-3123. [CrossRef] [PubMed]
53. Everard, A.; Cani, P.D. Diabetes, obesity and gut microbiota. Best Pract. Res. Clin. Gastroenterol. 2013, 27, 73-83. [CrossRef] [PubMed]
54. Turnbaugh, P.J.; Ley, R.E.; Mahowald, M.A.; Magrini, V.; Mardis, E.R.; Gordon, J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444, 1027-1031. [CrossRef] [PubMed]
55. Cani, P.D.; Amar, J.; Iglesias, M.A.; Poggi, M.; Knauf, C.; Bastelica, D.; Neyrinck, A.M.; Fava, F.; Tuohy, K.M.; Chabo, C. et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56, 1761-1772. [CrossRef] [PubMed]
56. Backhed, F.; Manchester, J.K.; Semenkovich, C.F.; Gordon, J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. USA 2007, 104, 979-984. [CrossRef] [PubMed]
57. Cani, P.D.; Bibiloni, R.; Knauf, C.; Waget, A.; Neyrinck, A.M.; Delzenne, N.M.; Burcelin, R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 2008, 57, 1470-1481. [CrossRef] [PubMed]
58. Amar, J.; Burcelin, R.; Ruidavets, J.B.; Cani, P.D.; Fauvel, J.; Alessi, M.C.; Chamontin, B.; Ferrieres, J. Energy intake is associated with endotoxemia in apparently healthy men. Am. J. Clin. Nutr. 2008, 87, 1219-1223. [PubMed]
59. Maron, D.F.; Smith, T.J.S.; Nachman, K.E. Restrictions on antimicrobial use in food animal production: An international regulatory and economic survey. Glob. Health 2013, 9, 48. [CrossRef] [PubMed]
60. Cazer, C.L.; Volkova, V.V.; Grohn, Y.T. Use of pharmacokinetic modeling to assess antimicrobial pressure on enteric bacteria of beef cattle fed chlortetracycline for growth promotion, disease control, or treatment. Foodborne Pathog. Dis. 2014, 11, 403-411. [CrossRef] [PubMed]
61. Van Boeckel, T.P.; Brower, C.; Gilbert, M.; Grenfell, B.T.; Levin, S.A.; Robinson, T.P.; Teillant, A.; Laxminarayan, R. Global trends in antimicrobial use in food animals. Proc. Natl. Acad. Sci. USA 2015, 112, 5649-5654. [CrossRef] [PubMed]
62. Johnson, T.A.; Stedtfeld, R.D.; Wang, Q.; Cole, J.R.; Hashsham, S.A.; Looft, T.; Zhu, Y.G.; Tiedje, J.M. Clusters of antibiotic resistance genes enriched together stay together in swine agriculture. mBio 2016. [CrossRef] [PubMed]
63. Cani, P.D.; Possemiers, S.; Van de Wiele, T.; Guiot, Y.; Everard, A.; Rottier, O.; Geurts, L.; Naslain, D.; Neyrinck, A.; Lambert, D.M. et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving glp-2-driven improvement of gut permeability. Gut 2009, 58, 1091-1103. [CrossRef] [PubMed]
64. Arslan, N. Obesity, fatty liver disease and intestinal microbiota. World J. Gastroenterol. 2014, 20, 16452-16463. [CrossRef] [PubMed]
65. Cani, P.D. Crosstalk between the gut microbiota and the endocannabinoid system: Impact on the gut barrier function and the adipose tissue. Clin. Microbiol. Infect. 2012, 18, 50-53. [CrossRef] [PubMed]
66. Membrez, M.; Blancher, F.; Jaquet, M.; Bibiloni, R.; Cani, P.D.; Burcelin, R.G.; Corthesy, I.; Mace, K.; Chou, C.J. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. Fed. Am. Soc. Exp. Biol. J. 2008, 22, 2416-2426. [CrossRef] [PubMed]
67. Pereira, S.S.; Alvarez-Leite, J.I. Low-grade inflammation, obesity, and diabetes. Curr. Obes. Rep. 2014, 3, 422-431. [CrossRef] [PubMed]
68. Ley, R.E.; Backhed, F.; Turnbaugh, P.; Lozupone, C.A.; Knight, R.D.; Gordon, J.I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 2005, 102, 11070-11075. [CrossRef] [PubMed]
69. Delzenne, N.M.; Cani, P.D. Interaction between obesity and the gut microbiota: Relevance in nutrition. Annu. Rev. Nutr. 2011, 31, 15-31. [CrossRef] [PubMed]
70. Abdallah Ismail, N.; Ragab, S.H.; Abd Elbaky, A.; Shoeib, A.R.; Alhosary, Y.; Fekry, D. Frequency of firmicutes and bacteroidetes in gut microbiota in obese and normal weight egyptian children and adults. Arch. Med. Sci. 2011, 7, 501-507. [CrossRef] [PubMed]
71. Clarke, S.F.; Murphy, E.F.; Nilaweera, K.; Ross, P.R.; Shanahan, F.; O’Toole, P.W.; Cotter, P.D. The gut microbiota and its relationship to diet and obesity: New insights. Gut Microb. 2012, 3, 186-202. [CrossRef] [PubMed]
72. Delzenne, N.M.; Neyrinck, A.M.; Backhed, F.; Cani, P.D. Targeting gut microbiota in obesity: Effects of prebiotics and probiotics. Nat. Rev. Endocrinol. 2011, 7, 639-646. [CrossRef] [PubMed]
73. Delzenne, N.M.; Neyrinck, A.M.; Cani, P.D. Modulation of the gut microbiota by nutrients with prebiotic properties: Consequences for host health in the context of obesity and metabolic syndrome. Microb. Cell Fact. 2011, 10, S10. [CrossRef] [PubMed]
74. Furet, J.P.; Kong, L.C.; Tap, J.; Poitou, C.; Basdevant, A.; Bouillot, J.L.; Mariat, D.; Corthier, G.; Dore, J.; Henegar, C. et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: Links with metabolic and low-grade inflammation markers. Diabetes 2010, 59, 3049-3057. [CrossRef] [PubMed]
75. Blaut, M. Gut microbiota and energy balance: Role in obesity. Proc. Nutr. Soc. 2015, 74, 227-234. [CrossRef] [PubMed]
76. Turnbaugh, P.J.; Ridaura, V.K.; Faith, J.J.; Rey, F.E.; Knight, R.; Gordon, J.I. The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Sci. Transl. Med. 2009, 1, 6ra14. [CrossRef] [PubMed]
77. Ridaura, V.K.; Faith, J.J.; Rey, F.E.; Cheng, J.; Duncan, A.E.; Kau, A.L.; Griffin, N.W.; Lombard, V.; Henrissat, B.; Bain, J.R. et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 2013, 341, 1241214. [CrossRef] [PubMed]
78. Serino, M.; Luche, E.; Gres, S.; Baylac, A.; Berge, M.; Cenac, C.; Waget, A.; Klopp, P.; Iacovoni, J.; Klopp, C. et al. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 2012, 61, 543-553. [CrossRef] [PubMed]
79. Neyrinck, A.M.; Van Hee, V.F.; Piront, N.; De Backer, F.; Toussaint, O.; Cani, P.D.; Delzenne, N.M. Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice. Nutr. Diabetes 2012, 2, e28. [CrossRef] [PubMed]
80. Sommer, F.; Stahlman, M.; Ilkayeva, O.; Arnemo, J.M.; Kindberg, J.; Josefsson, J.; Newgard, C.B.; Frobert, O.; Backhed, F. The gut microbiota modulates energy metabolism in the hibernating brown bear Ursus arctos. Cell Rep. 2016, 14, 1655-1661. [CrossRef] [PubMed]
81. Arinell, K.; Sahdo, B.; Evans, A.L.; Arnemo, J.M.; Baandrup, U.; Frobert, O. Brown bears (Ursus arctos) seem resistant to atherosclerosis despite highly elevated plasma lipids during hibernation and active state. Clin. Transl. Sci. 2012, 5, 269-272. [CrossRef] [PubMed]
82. Mar Rodriguez, M.; Perez, D.; Javier Chaves, F.; Esteve, E.; Marin-Garcia, P.; Xifra, G.; Vendrell, J.; Jove, M.; Pamplona, R.; Ricart, W. et al. Obesity changes the human gut mycobiome. Sci. Rep. 2015, 5, 14600. [CrossRef] [PubMed]
83. McGuire, M.T.; Wing, R.R.; Hill, J.O. The prevalence of weight loss maintenance among american adults. Int. J. Obes. Relat. Metab. Disord. 1999, 23, 1314-1319. [CrossRef] [PubMed]
84. Field, A.E.; Malspeis, S.; Willett, W.C. Weight cycling and mortality among middle-aged or older women. Arch. Intern. Med. 2009, 169, 881-886. [CrossRef] [PubMed]
85. Hamm, P.; Shekelle, R.B.; Stamler, J. Large fluctuations in body weight during young adulthood and twenty-five-year risk of coronary death in men. Am. J. Epidemiol. 1989, 129, 312-318. [PubMed]
86. Chevrier, J.; Dewailly, E.; Ayotte, P.; Mauriege, P.; Despres, J.P.; Tremblay, A. Body weight loss increases plasma and adipose tissue concentrations of potentially toxic pollutants in obese individuals. Int. J. Obes. Relat. Metab. Disord. 2000, 24, 1272-1278. [CrossRef] [PubMed]
87. Hue, O.; Marcotte, J.; Berrigan, F.; Simoneau, M.; Dore, J.; Marceau, P.; Marceau, S.; Tremblay, A.; Teasdale, N. Increased plasma levels of toxic pollutants accompanying weight loss induced by hypocaloric diet or by bariatric surgery. Obes. Surg. 2006, 16, 1145-1154. [CrossRef] [PubMed]
88. Kim, M.J.; Marchand, P.; Henegar, C.; Antignac, J.P.; Alili, R.; Poitou, C.; Bouillot, J.L.; Basdevant, A.; Le Bizec, B.; Barouki, R. et al. Fate and complex pathogenic effects of dioxins and polychlorinated biphenyls in obese subjects before and after drastic weight loss. Environ. Health Perspect. 2011, 119, 377-383. [CrossRef] [PubMed]
89. Kantartzis, K.; Machann, J.; Schick, F.; Rittig, K.; Machicao, F.; Fritsche, A.; Haring, H.U.; Stefan, N. Effects of a lifestyle intervention in metabolically benign and malign obesity. Diabetologia 2011, 54, 864-868. [CrossRef] [PubMed]
90. Shin, M.J.; Hyun, Y.J.; Kim, O.Y.; Kim, J.Y.; Jang, Y.; Lee, J.H. Weight loss effect on inflammation and ldl oxidation in metabolically healthy but obese (mho) individuals: Low inflammation and ldl oxidation in mho women. Int. J. Obes. 2006, 30, 1529-1534. [CrossRef] [PubMed]
91. McLaughlin, T.; Abbasi, F.; Lamendola, C.; Liang, L.; Reaven, G.; Schaaf, P.; Reaven, P. Differentiation between obesity and insulin resistance in the association with c-reactive protein. Circulation 2002, 106, 2908-2912. [CrossRef] [PubMed]
92. Janiszewski, P.M.; Ross, R. Effects of weight loss among metabolically healthy obese men and women. Diabetes Care 2010, 33, 1957-1959. [CrossRef] [PubMed]
93. Cui, Z.; Truesdale, K.P.; Bradshaw, P.T.; Cai, J.; Stevens, J. Three-year weight change and cardiometabolic risk factors in obese and normal weight adults who are metabolically healthy: The atherosclerosis risk in communities study. Int. J. Obes. 2015, 39, 1203-1208. [CrossRef] [PubMed]
94. Dalzill, C.; Nigam, A.; Juneau, M.; Guilbeault, V.; Latour, E.; Mauriege, P.; Gayda, M. Intensive lifestyle intervention improves cardiometabolic and exercise parameters in metabolically healthy obese and metabolically unhealthy obese individuals. Can. J. Cardiol. 2014, 30, 434-440. [CrossRef] [PubMed]
95. Liu, R.H.; Wharton, S.; Sharma, A.M.; Ardern, C.I.; Kuk, J.L. Influence of a clinical lifestyle-based weight loss program on the metabolic risk profile of metabolically normal and abnormal obese adults. Obesity 2013, 21, 1533-1539. [CrossRef] [PubMed]
96. Sesti, G.; Folli, F.; Perego, L.; Hribal, M.L.; Pontiroli, A.E. Effects of weight loss in metabolically healthy obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet. PLoS ONE 2011, 6, e17737. [CrossRef] [PubMed]
97. Gilardini, L.; Vallone, L.; Cottafava, R.; Redaelli, G.; Croci, M.; Conti, A.; Pasqualinotto, L.; Invitti, C. Insulin sensitivity deteriorates after short-term lifestyle intervention in the insulin sensitive phenotype of obesity. Obes. Facts 2012, 5, 68-76. [CrossRef] [PubMed]
98. Karelis, A.D.; Messier, V.; Brochu, M.; Rabasa-Lhoret, R. Metabolically healthy but obese women: Effect of an energy-restricted diet. Diabetologia 2008, 51, 1752-1754. [CrossRef] [PubMed]
99. Evangelou, P.; Tzotzas, T.; Christou, G.; Elisaf, M.S.; Kiortsis, D.N. Does the presence of metabolic syndome influence weight loss in obese and overweight women? Metab. Syndr. Relat. Disord. 2010, 8, 173-178. [CrossRef] [PubMed]
100. Nagao, K.; Yanagita, T. Bioactive lipids in metabolic syndrome. Prog. Lipid Res. 2008, 47, 127-146. [CrossRef] [PubMed]
101. Nagao, K.; Yanagita, T. Medium-chain fatty acids: Functional lipids for the prevention and treatment of the metabolic syndrome. Pharmacol. Res. 2010, 61, 208-212. [CrossRef] [PubMed]
102. Babayan, V.K. Medium chain triglycerides and structured lipids. Lipids 1987, 22, 417-420. [CrossRef] [PubMed]
103. Bach, A.C.; Babayan, V.K. Medium-chain triglycerides: An update. Am. J. Clin. Nutr. 1982, 36, 950-962. [PubMed]
104. Jensen, R.G. The composition of bovine milk lipids: January 1995 to december 2000. J. Dairy Sci. 2002, 85, 295-350. [CrossRef]
105. Papamandjaris, A.A.; MacDougall, D.E.; Jones, P.J. Medium chain fatty acid metabolism and energy expenditure: Obesity treatment implications. Life Sci. 1998, 62, 1203-1215. [CrossRef]
106. Marten, B.; Pfeuffer, M.; Schrezenmeir, J. Medium-chain triglycerides. Int. Dairy J. 2006, 16, 1374-1382. [CrossRef]
107. Noguchi, O.; Takeuchi, H.; Kubota, F.; Tsuji, H.; Aoyama, T. Larger diet-induced thermogenesis and less body fat accumulation in rats fed medium-chain triacylglycerols than in those fed long-chain triacylglycerols. J. Nutr. Sci. Vitaminol. 2002, 48, 524-529. [CrossRef] [PubMed]
108. Akpa, M.M.; Point, F.; Sawadogo, S.; Radenne, A.; Mounier, C. Inhibition of insulin and t3-induced fatty acid synthase by hexanoate. Lipids 2010, 45, 997-1009. [CrossRef] [PubMed]
109. Kersten, S. Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep. 2001, 2, 282-286. [CrossRef] [PubMed]
110. Ambati, S.; Li, Q.; Rayalam, S.; Hartzell, D.L.; Della-Fera, M.A.; Hamrick, M.W.; Baile, C.A. Central leptin versus ghrelin: Effects on bone marrow adiposity and gene expression. Endocrine 2010, 37, 115-123. [CrossRef] [PubMed]
111. Berlanga, A.; Guiu-Jurado, E.; Porras, J.A.; Auguet, T. Molecular pathways in non-alcoholic fatty liver disease. Clin. Exp. Gastroenterol. 2014, 7, 221-239. [PubMed]
112. Goodridge, A.G.; Thurmond, D.C.; Baillie, R.A.; Hodnett, D.W.; Xu, G. Nutritional and hormonal regulation of the gene for malic enzyme. Z. Ernahrungswissenschaft 1998, 37, 8-13.
113. Roncero, C.; Goodridge, A.G. Hexanoate and octanoate inhibit transcription of the malic enzyme and fatty acid synthase genes in chick embryo hepatocytes in culture. J. Biol. Chem. 1992, 267, 14918-14927. [PubMed]
114. Thurmond, D.C.; Baillie, R.A.; Goodridge, A.G. Regulation of the action of steroid/thyroid hormone receptors by medium-chain fatty acids. J. Biol. Chem. 1998, 273, 15373-15381. [CrossRef] [PubMed]
115. Wang, B.; Fu, J.; Li, L.; Gong, D.; Wen, X.; Yu, P.; Zeng, Z. Medium-chain fatty acid reduces lipid accumulation by regulating expression of lipid-sensing genes in human liver cells with steatosis. Int. J. Food Sci. Nutr. 2016, 67, 288-297. [CrossRef] [PubMed]
116. Lieber, C.S.; Lefevre, A.; Spritz, N.; Feinman, L.; DeCarli, L.M. Difference in hepatic metabolism of long-and medium-chain fatty acids: The role of fatty acid chain length in the production of the alcoholic fatty liver. J. Clin. Investig. 1967, 46, 1451-1460. [CrossRef] [PubMed]
117. Ling, P.R.; Hamawy, K.J.; Moldawer, L.L.; Istfan, N.; Bistrian, B.R.; Blackburn, G.L. Evaluation of the protein quality of diets containing medium-and long-chain triglyceride in healthy rats. J. Nutr. 1986, 116, 343-349. [PubMed]
118. Traul, K.A.; Driedger, A.; Ingle, D.L.; Nakhasi, D. Review of the toxicologic properties of medium-chain triglycerides. Food Chem. Toxicol. 2000, 38, 79-98. [CrossRef]
119. Hill, J.O.; Peters, J.C.; Yang, D.; Sharp, T.; Kaler, M.; Abumrad, N.N.; Greene, H.L. Thermogenesis in humans during overfeeding with medium-chain triglycerides. Metab. Clin. Exp. 1989, 38, 641-648. [CrossRef]
120. Seaton, T.B.; Welle, S.L.; Warenko, M.K.; Campbell, R.G. Thermic effect of medium-chain and long-chain triglycerides in man. Am. J. Clin. Nutr. 1986, 44, 630-634. [PubMed]
121. Scalfi, L.; Coltorti, A.; Contaldo, F. Postprandial thermogenesis in lean and obese subjects after meals supplemented with medium-chain and long-chain triglycerides. Am. J. Clin. Nutr. 1991, 53, 1130-1133. [PubMed]
122. Dulloo, A.G.; Fathi, M.; Mensi, N.; Girardier, L. Twenty-four-hour energy expenditure and urinary catecholamines of humans consuming low-to-moderate amounts of medium-chain triglycerides: A dose-response study in a human respiratory chamber. Eur. J. Clin. Nutr. 1996, 50, 152-158. [PubMed]
123. Ishizawa, R.; Masuda, K.; Sakata, S.; Nakatani, A. Effects of different fatty acid chain lengths on fatty acid oxidation-related protein expression levels in rat skeletal muscles. J. Oleo Sci. 2015, 64, 415-421. [CrossRef] [PubMed]
124. Binnert, C.; Pachiaudi, C.; Beylot, M.; Hans, D.; Vandermander, J.; Chantre, P.; Riou, J.P.; Laville, M. Influence of human obesity on the metabolic fate of dietary long-and medium-chain triacylglycerols. Am. J. Clin. Nutr. 1998, 67, 595-601. [PubMed]
125. Nagata, J.; Kasai, M.; Watanabe, S.; Ikeda, I.; Saito, M. Effects of highly purified structured lipids containing medium-chain fatty acids and linoleic acid on lipid profiles in rats. Biosci. Biotechnol. Biochem. 2003, 67, 1937-1943. [CrossRef] [PubMed]
126. Nagata, J.; Kasai, M.; Negishi, S.; Saito, M. Effects of structured lipids containing eicosapentaenoic or docosahexaenoic acid and caprylic acid on serum and liver lipid profiles in rats. BioFactors 2004, 22, 157-160. [CrossRef] [PubMed]
127. Matsuo, T.; Matsuo, M.; Kasai, M.; Takeuchi, H. Effects of a liquid diet supplement containing structured medium-and long-chain triacylglycerols on bodyfat accumulation in healthy young subjects. Asia Pac. J. Clin. Nutr. 2001, 10, 46-50. [CrossRef] [PubMed]
128. Tsuji, H.; Kasai, M.; Takeuchi, H.; Nakamura, M.; Okazaki, M.; Kondo, K. Dietary medium-chain triacylglycerols suppress accumulation of body fat in a double-blind, controlled trial in healthy men and women. J. Nutr. 2001, 131, 2853-2859. [PubMed]
129. St-Onge, M.P.; Mayrsohn, B.; O’Keeffe, M.; Kissileff, H.R.; Choudhury, A.R.; Laferrere, B. Impact of medium and long chain triglycerides consumption on appetite and food intake in overweight men. Eur. J. Clin. Nutr. 2014, 68, 1134-1140. [CrossRef] [PubMed]
130. St-Onge, M.P.; Ross, R.; Parsons, W.D.; Jones, P.J. Medium-chain triglycerides increase energy expenditure and decrease adiposity in overweight men. Obes. Res. 2003, 11, 395-402. [CrossRef] [PubMed]
131. Lemarie, F.; Beauchamp, E.; Dayot, S.; Duby, C.; Legrand, P.; Rioux, V. Dietary caprylic acid (c8:0) does not increase plasma acylated ghrelin but decreases plasma unacylated ghrelin in the rat. PLoS ONE 2015, 10, e0133600. [CrossRef] [PubMed]
132. Lemarie, F.; Beauchamp, E.; Legrand, P.; Rioux, V. Revisiting the metabolism and physiological functions of caprylic acid (c8:0) with special focus on ghrelin octanoylation. Biochimie 2016, 120, 40-48. [CrossRef] [PubMed]
133. Li, Z.; Mulholland, M.; Zhang, W. Ghrelin o-acyltransferase (goat) and energy metabolism. Sci. China Life Sci. 2016, 59, 281-291. [CrossRef] [PubMed]
134. Kasai, M.; Nosaka, N.; Maki, H.; Negishi, S.; Aoyama, T.; Nakamura, M.; Suzuki, Y.; Tsuji, H.; Uto, H.; Okazaki, M. et al. Effect of dietary medium-and long-chain triacylglycerols (mlct) on accumulation of body fat in healthy humans. Asia Pac. J. Clin. Nutr. 2003, 12, 151-160. [PubMed]
135. St-Onge, M.P.; Bourque, C.; Jones, P.J.; Ross, R.; Parsons, W.E. Medium-versus long-chain triglycerides for 27 days increases fat oxidation and energy expenditure without resulting in changes in body composition in overweight women. Int. J. Obes. Relat. Metab. Disord. 2003, 27, 95-102. [CrossRef] [PubMed]
136. St-Onge, M.P.; Jones, P.J. Greater rise in fat oxidation with medium-chain triglyceride consumption relative to long-chain triglyceride is associated with lower initial body weight and greater loss of subcutaneous adipose tissue. Int. J. Obes. Relat. Metab. Disord. 2003, 27, 1565-1571. [CrossRef] [PubMed]
137. Airhart, S.; Cade, W.T.; Jiang, H.; Coggan, A.R.; Racette, S.B.; Korenblat, K.; Spearie, C.A.; Waller, S.; O’Connor, R.; Bashir, A. et al. A diet rich in medium-chain fatty acids improves systolic function and alters the lipidomic profile in patients with type 2 diabetes: A pilot study. J. Clin. Endocrinol. Metab. 2016, 101, 504-512. [CrossRef] [PubMed]
138. Assuncao, M.L.; Ferreira, H.S.; dos Santos, A.F.; Cabral, C.R., Jr.; Florencio, T.M. Effects of dietary coconut oil on the biochemical and anthropometric profiles of women presenting abdominal obesity. Lipids 2009, 44, 593-601. [CrossRef] [PubMed]
139. Rimbach, G.; Melchin, M.; Moehring, J.; Wagner, A.E. Polyphenols from cocoa and vascular health—A critical review. Int. J. Mol. Sci. 2009, 10, 4290-4309. [CrossRef] [PubMed]
140. Bourque, C.; St-Onge, M.P.; Papamandjaris, A.A.; Cohn, J.S.; Jones, P.J. Consumption of an oil composed of medium chain triacyglycerols, phytosterols, and n-3 fatty acids improves cardiovascular risk profile in overweight women. Metabol. Clin. Exp. 2003, 52, 771-777. [CrossRef]
141. St-Onge, M.P.; Lamarche, B.; Mauger, J.F.; Jones, P.J. Consumption of a functional oil rich in phytosterols and medium-chain triglyceride oil improves plasma lipid profiles in men. J. Nutr. 2003, 133, 1815-1820. [PubMed]
142. St-Onge, M.P.; Bosarge, A.; Goree, L.L.; Darnell, B. Medium chain triglyceride oil consumption as part of a weight loss diet does not lead to an adverse metabolic profile when compared to olive oil. J. Am. Coll. Nutr. 2008, 27, 547-552. [CrossRef] [PubMed]
143. Mumme, K.; Stonehouse, W. Effects of medium-chain triglycerides on weight loss and body composition: A meta-analysis of randomized controlled trials. J. Acad. Nutr. Diet. 2015, 115, 249-263. [CrossRef] [PubMed]
144. Mori, N.; Nakanishi, S.; Shiomi, S.; Kiyokawa, S.; Kakimoto, S.; Nakagawa, K.; Hosoe, K.; Minami, K.; Nadamoto, T. Enhancement of fat oxidation by licorice flavonoid oil in healthy humans during light exercise. J. Nutr. Sci. Vitaminol. 2015, 61, 406-416. [CrossRef] [PubMed]
145. Isaacs, C.E. The antimicrobial function of milk lipids. Adv. Nutr. Res. 2001, 10, 271-285. [PubMed]
146. Rios-Covian, D.; Ruas-Madiedo, P.; Margolles, A.; Gueimonde, M.; de Los Reyes-Gavilan, C.G.; Salazar, N. Intestinal short chain fatty acids and their link with diet and human health. Front. Microbiol. 2016, 7, 185. [CrossRef] [PubMed]
147. Schanler, R.J.; Goldblum, R.M.; Garza, C.; Goldman, A.S. Enhanced fecal excretion of selected immune factors in very low birth weight infants fed fortified human milk. Pediatr. Res. 1986, 20, 711-715. [CrossRef] [PubMed]
148. Papavassilis, C.; Mach, K.K.; Mayser, P.A. Medium-chain triglycerides inhibit growth of malassezia: Implications for prevention of systemic infection. Crit. Care Med. 1999, 27, 1781-1786. [CrossRef] [PubMed]
149. Kono, H.; Fujii, H.; Asakawa, M.; Yamamoto, M.; Matsuda, M.; Maki, A.; Matsumoto, Y. Protective effects of medium-chain triglycerides on the liver and gut in rats administered endotoxin. Ann. Surg. 2003, 237, 246-255. [CrossRef] [PubMed]
150. Zentek, J.; Buchheit-Renko, S.; Ferrara, F.; Vahjen, W.; Van Kessel, A.G.; Pieper, R. Nutritional and physiological role of medium-chain triglycerides and medium-chain fatty acids in piglets. Anim. Health Res. Rev. 2011, 12, 83-93. [CrossRef] [PubMed]
151. Zentek, J.; Ferrara, F.; Pieper, R.; Tedin, L.; Meyer, W.; Vahjen, W. Effects of dietary combinations of organic acids and medium chain fatty acids on the gastrointestinal microbial ecology and bacterial metabolites in the digestive tract of weaning piglets. J. Anim. Sci. 2013, 91, 3200-3210. [CrossRef] [PubMed]
152. Dierick, N.; Michiels, J.; Van Nevel, C. Effect of medium chain fatty acids and benzoic acid, as alternatives for antibiotics, on growth and some gut parameters in piglets. Commun. Agric. Appl. Biol. Sci. 2004, 69, 187-190. [PubMed]
153. Jacobi, S.K.; Odle, J. Nutritional factors influencing intestinal health of the neonate. Adv. Nutr. 2012, 3, 687-696. [CrossRef] [PubMed]
154. Kono, H.; Fujii, H.; Ogiku, M.; Tsuchiya, M.; Ishii, K.; Hara, M. Enteral diets enriched with medium-chain triglycerides and n-3 fatty acids prevent chemically induced experimental colitis in rats. Transl. Res. J. Lab. Clin. Med. 2010, 156, 282-291. [CrossRef] [PubMed]
155. Kono, H.; Fujii, H.; Ishii, K.; Hosomura, N.; Ogiku, M. Dietary medium-chain triglycerides prevent chemically induced experimental colitis in rats. Transl. Res. J. Lab. Clin. Med. 2010, 155, 131-141. [CrossRef] [PubMed]
156. Decuypere, J.A.; Dierick, N.A. The combined use of triacylglycerols containing medium-chain fatty acids and exogenous lipolytic enzymes as an alternative to in-feed antibiotics in piglets: Concept, possibilities and limitations. An overview. Nutr. Res. Rev. 2003, 16, 193-210. [CrossRef] [PubMed]
157. Liu, Y. Fatty acids, inflammation and intestinal health in pigs. J. Anim. Sci. Biotechnol. 2015, 6, 41. [CrossRef] [PubMed]
158. Kono, H.; Fujii, H.; Asakawa, M.; Maki, A.; Amemiya, H.; Hirai, Y.; Matsuda, M.; Yamamoto, M. Medium-chain triglycerides enhance secretory iga expression in rat intestine after administration of endotoxin. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 286, G1081-G1089. [CrossRef] [PubMed]
159. Servier Medical Art (Servier). Available online: http://www.servier.fr/smart/banque-dimages-powerpoint/ (acessed on 21 March 2016).